R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Senior Oncology Account Manager

Field SalesConfirmed live in the last 24 hours
Full-timeRemote in USA$150k - $230k

About the Job

Requirements

  • Hold an MA, MS, BA, or BS degree and have 12–15+ years of biopharma industry experience.
  • Have 8–12+ years of prior experience in oncology product sales.
  • Have a proven track record of product launch success in the oncology therapeutic space.
  • Have experience with oral oncolytic product launches.
  • Have experience launching oncology products with companion diagnostics.
  • Have a proven performance record in highly competitive marketplaces and solo-representative selling environments.
  • Have demonstrated success operating in small- or midsize biotechnology environments.
  • Be able to meet territorial travel requirements and travel to meetings, training, and programs as necessary.
  • Have proven effectiveness in highly collaborative, cross-functional working environments.
  • Hold a valid driver's license.
  • Permanently reside in the territory for which the employee is accountable.
  • Be able to travel approximately 50% of the time.
  • Have experience in the NSCLC oncology space.
  • Have an advanced degree such as an MBA, PharmD, or PhD.
  • Have strong organization, planning, project management, technical, and analytical skills.
  • Be able to work independently to execute strategic and tactical plans under tight timelines.
  • Deliver compelling presentations to individuals and groups, adapting messaging to maximize audience engagement.
  • Be highly proficient in Microsoft PowerPoint, Excel, and Word.

Responsibilities

  • Market Revolution Medicines’ product portfolio effectively in the designated territory.
  • Exceed assigned territory performance goals by positioning the benefits and use of Revolution Medicines’ products for appropriate patients.
  • Manage time effectively by prioritizing engagements that drive brand value and activities that positively impact patients.
  • Partner with key internal stakeholders to remove barriers to care and help ensure eligible patients receive timely access to Revolution Medicines’ products.
  • Flex between virtual and in-person engagements and develop business plans that consider account communication preferences.
  • Analyze market data and translate insights into business plans, then implement them by engaging key targets through call optimization and resource utilization.
  • Develop sustained customer relationships across assigned accounts and proactively challenge customers with innovative, value-driven solutions.
  • Represent Revolution Medicines’ brands professionally, compliantly, ethically, and effectively.
  • Maintain a thorough understanding of disease states, company products, and relevant competitors, and articulate product value across digital and in-person communication channels.
  • Understand reimbursement processes and fulfillment pathways for oral oncolytics.
  • Manage the territory effectively and apply strong selling competencies.
  • Develop creative ways to gain customer access.
  • Drive team effectiveness and shared goals by leveraging and sharing expertise and information.
  • Manage territory resources and budget effectively.
  • Comply with laws, regulations, and policies governing Revolution Medicines staff.
  • Model corporate core values and cultivate an energized team culture focused on patient impact.

Desired Qualifications

  • Experience in the NSCLC oncology space.
  • An advanced degree such as an MBA, PharmD, or PhD.
  • Strong organization, planning, project management, technical, and analytical skills.
  • Relevant experience such as sales operations, market research, or market access.
  • Ability to work independently to execute strategic and tactical plans under tight timelines.
  • Ability to deliver compelling presentations to individuals and groups, adapting messaging to maximize audience engagement.
  • High proficiency in Microsoft PowerPoint, Excel, and Word.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs